NanoViricides Signs Confidential Disclosure Agreement with International Pharmaceutical Company to Explore Collaborating on its COVID-19 Program
SHELTON, CT / ACCESSWIRE / May 4, 2020 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company") a leader in the development...